Company research
Oscar Health, Inc.
CIK 1568651Updated Sep 26, 2026
SecurityOSCR · NYSE · equity
Name history
Oscar Health, Inc. · through Sep 22, 2026Mulberry Health Inc. · through Dec 17, 2020
OSCR price & chart
Loading TradingView…
NYSE:OSCR on TradingView ↗About the company
Oscar Health, Inc. (“Oscar”) is a leading healthcare technology company built around a full stack technology platform and a relentless focus on serving our members. Oscar has been challenging the status quo in the healthcare system since its founding in 2012, and is dedicated to making a healthier life accessible and affordable for all. Oscar offers Individual & Family plans and health technology solutions that power the healthcare industry through +Oscar. Oscar’s technology drives superior experiences, deep engagement, and high-value clinical care, earning us the trust of approximately 2.0 million members, as of June 30, 2025.
In the news
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 6,325,411,000Source | 4,840,496,000Source | 3,601,480,000Source | 4,526,601,000Source |
| Property, Plant and Equipment, NetUSD | 88,350,000Source | 66,793,000Source | 61,930,000Source | 59,888,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 2,774,151,000Source | 1,527,186,000Source | 1,870,315,000Source | 1,558,595,000Source |
| Assets, CurrentUSD | 4,613,404,000Source | 2,845,174,000Source | 3,061,100,000Source | 4,121,555,000Source |
| Operating Lease, Right-of-Use AssetUSD | 51,544,000Source | 57,153,000Source | 62,873,000Source | 68,001,000Source |
| Other Assets, NoncurrentUSD | 119,719,000Source | 82,397,000Source | 83,271,000Source | 94,756,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 5,344,676,000Source | 3,824,071,000Source | 2,795,363,000Source | 3,634,201,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | — | — | — | 0Source |
| Additional Paid in CapitalUSD | 4,256,972,000Source | 3,869,617,000Source | 3,682,294,000Source | 3,509,007,000Source |
| Retained Earnings (Accumulated Deficit)USD | -3,294,434,000Source | -2,851,283,000Source | -2,876,715,000Source | -2,605,987,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 18,030,000Source | -1,827,000Source | 1,309,000Source | -9,715,000Source |
| Stockholders' Equity Attributable to ParentUSD | 977,648,000Source | 1,013,586,000Source | 803,967,000Source | 890,384,000Source |
| Liabilities and EquityUSD | 6,325,411,000Source | 4,840,496,000Source | 3,601,480,000Source | 4,526,601,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 4,862,587,000Source | 3,463,234,000Source | 2,429,012,000Source | 3,263,922,000Source |
| Operating Lease, Liability, CurrentUSD | 16,716,000Source | 13,548,000Source | 14,175,000Source | 12,824,000Source |
| Operating Lease, Liability, NoncurrentUSD | 51,991,000Source | 60,651,000Source | 66,803,000Source | 72,175,000Source |
| Other Liabilities, NoncurrentUSD | 51,994,000Source | 61,282,000Source | 67,574,000Source | 72,280,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 3,087,000Source | 2,839,000Source | 2,150,000Source | 2,016,000Source |
| Additional Financial Items | ||||
| Long-term Debt, Excluding Current MaturitiesUSD | 430,095,000Source | 299,555,000Source | 298,777,000Source | 297,999,000Source |
| Short-term InvestmentsUSD | — | 624,461,000Source | — | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | -442,903,000Source | 26,121,000Source | -270,594,000Source | -609,552,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 28,892,000Source | 32,145,000Source | 30,694,000Source | 15,283,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 87,654,000Source | 109,824,000Source | 159,683,000Source | 112,329,000Source |
| Deferred Income Tax Expense (Benefit)USD | 2,449,000Source | -2,338,000Source | 58,000Source | -165,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 1,094,854,000Source | 978,193,000Source | -272,159,000Source | 380,349,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -241,060,000Source | -1,387,434,000Source | 577,187,000Source | -226,519,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 4,035,000Source | — | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 399,211,000Source | 68,388,000Source | 6,446,000Source | 301,110,000Source |
| Repayments of Long-term DebtUSD | — | — | 0Source | 0Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 1,253,005,000Source | -340,853,000Source | 311,474,000Source | 454,940,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 2,804,123,000Source | 1,551,118,000Source | 1,891,971,000Source | 1,580,497,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 12,783,000Source | 33,691,000Source | 23,156,000Source | 10,079,000Source |
| Income Taxes Paid, NetUSD | 17,516,000Source | 674,000Source | 2,414,000Source | 1,893,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 100,400,000Source | 119,000,000Source | 166,841,000Source | 112,329,000Source |
| Amortization of Debt Issuance CostsUSD | 1,630,000Source | 778,000Source | 778,000Source | 713,000Source |
| Gain (Loss) on InvestmentsUSD | — | — | — | -1,274,000Source |
| Gain (Loss) on Sale of InvestmentsUSD | 1,339,000Source | 23,000Source | -70,000Source | -1,274,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | 0Source | 0Source |
| General and Administrative ExpenseUSD | 28,892,000Source | 32,145,000Source | 339,716,000Source | 309,783,000Source |
| Income Tax Expense (Benefit)USD | 5,606,000Source | 7,305,000Source | 3,294,000Source | -523,000Source |
| InterestExpenseNonoperatingUSD | 17,601,000Source | 23,734,000Source | — | — |
| Liability for Unpaid Claims and Claims Adjustment Expense, Incurred ClaimsUSD | 10,106,068,000Source | 7,441,081,000Source | 4,747,589,000Source | 3,398,339,000Source |
| Net Income (Loss) Attributable to ParentUSD | -443,151,000Source | 25,432,000Source | -270,728,000Source | -606,275,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 248,000Source | 689,000Source | 134,000Source | -3,277,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -443,151,000Source | — | — | -606,275,000Source |
| Nonoperating Income (Expense)USD | -23,339,000Source | -105,000Source | -7,082,000Source | — |
| Other Operating Income (Expense), NetUSD | — | — | — | 2,415,000Source |
| Proceeds from Contributions from AffiliatesUSD | 0Source | 0Source | 2,490,000Source | 1,846,000Source |
| Proceeds from Issuance of Long-term DebtUSD | 410,000,000Source | 0Source | 0Source | 305,000,000Source |
| Proceeds from Issuance of Redeemable Preferred StockUSD | — | — | — | 0Source |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | 670,724,000Source | 744,794,000Source | 1,410,166,000Source | 633,467,000Source |
| Proceeds from Noncontrolling InterestsUSD | — | — | 0Source | 0Source |
| Proceeds from Stock Options ExercisedUSD | 55,033,000Source | 68,388,000Source | 3,956,000Source | 1,299,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 11,701,427,000Source | 9,177,564,000Source | 5,862,869,000Source | 3,963,638,000Source |
| Selling, General and Administrative ExpenseUSD | 2,049,867,000Source | 1,755,565,000Source | — | — |
| Operating Income (Loss)USD | -396,357,000Source | 57,265,000Source | -235,615,000Source | -589,867,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -437,297,000Source | 33,426,000Source | -267,300,000Source | -610,075,000Source |
| Income Tax Expense (Benefit)USD | 5,606,000Source | 7,305,000Source | 3,294,000Source | -523,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 248,000Source | 689,000Source | 134,000Source | -3,277,000Source |
| Net Income (Loss) Attributable to ParentUSD | -443,151,000Source | 25,432,000Source | -270,728,000Source | -606,275,000Source |
| Earnings Per Share, BasicUSD per share | -1.69Source | 0.11Source | -1.22Source | -2.85Source |
| Earnings Per Share, DilutedUSD per share | -1.69Source | 0.1Source | -1.22Source | -2.85Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 262,388,000Source | 240,386,000Source | 221,655,493Source | 212,474,615Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 262,388,000Source | 265,853,000Source | 221,655,493Source | 212,474,615Source |
| Interest Expense (non-operating)USD | 17,601,000Source | 23,734,000Source | — | — |
| Additional Financial Items | ||||
| Benefits, Losses and ExpensesUSD | 12,097,784,000Source | 9,120,299,000Source | 6,098,484,000Source | 4,553,505,000Source |
| Current Income Tax Expense (Benefit)USD | 3,157,000Source | 9,643,000Source | 3,236,000Source | -358,000Source |
| Gain (Loss) on InvestmentsUSD | — | — | — | -1,274,000Source |
| General and Administrative ExpenseUSD | 28,892,000Source | 32,145,000Source | 339,716,000Source | 309,783,000Source |
| Interest ExpenseUSD | — | — | 24,603,000Source | 22,623,000Source |
| Liability for Unpaid Claims and Claims Adjustment Expense, Incurred ClaimsUSD | 10,106,068,000Source | 7,441,081,000Source | 4,747,589,000Source | 3,398,339,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -443,151,000Source | — | — | -606,275,000Source |
| Net Investment IncomeUSD | 202,941,000Source | 185,729,000Source | 155,447,000Source | 31,306,000Source |
| Nonoperating Income (Expense)USD | -23,339,000Source | -105,000Source | -7,082,000Source | — |
| Other Operating Income (Expense), NetUSD | — | — | — | 2,415,000Source |
Filing attachments
d74904dex41.htm · 8-K · 2025-09-18
EX-4.1 2 d74904dex41.htm EX-4.1 EX-4.1 Exhibit 4.1 EXECUTION VERSION OSCAR HEALTH, INC. and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION as Trustee - - - - - - - - - - - - - - - - - - - - - INDENTURE Dated as of September 18, 2025 - - - - - - - - - - - - - - - - - - - - - 2.25% Convertible Senior Subordinated Notes due 2030 TABLE OF CONTENTS …
Read attachment ↗d944721dex991.htm · 8-K · 2025-09-16
EX-99.1 2 d944721dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Oscar Health, Inc. News Release Oscar Health Prices Upsized $355,000,000 Convertible Senior Subordinated Notes Offering to Scale Long-Term Growth and Consumer and Employer Adoption of the Individual Market Net proceeds to support general corporate purposes, including future expansion opportunities fueled by strategic AI and member experience initiatives as well as the potential extension of enhanced premium tax credits Attr…
Read attachment ↗d944718dex991.htm · 8-K · 2025-09-15
EX-99.1 2 d944718dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Oscar Health, Inc. News Release Oscar Health Launches Proposed Convertible Senior Subordinated Notes Offering to Scale Long-Term Growth and Consumer and Employer Adoption of the Individual Market Net proceeds to support general corporate purposes, including future expansion opportunities fueled by strategic AI and member experience initiatives as well as the potential extension of enhanced premium tax credits Attractive cos…
Read attachment ↗